Literature DB >> 9486819

Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer.

W E Fisher1, T A Doran, P Muscarella, L G Boros, E C Ellison, W J Schirmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9486819     DOI： 10.1093/jnci/90.4.322

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  SST3-selective potent peptidic somatostatin receptor antagonists.

Authors:  J C Reubi; J C Schaer; S Wenger; C Hoeger; J Erchegyi; B Waser; J Rivier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  Defining the cancer master switch.

Authors:  Courtney J Balentine; David H Berger; Shi-He Liu; Changyi Chen; John Nemunaitis; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

3.  Epidermal growth factor receptor, somatostatin and bcl-2 in human pancreatic tumor xenografts. An immunohistochemical study.

Authors:  A Zalatnai
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

4.  Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.

Authors:  Ylberta Kajtazi; Daniel Kaemmerer; Jörg Sänger; Stefan Schulz; Amelie Lupp
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-26       Impact factor: 4.553

Review 5.  Somatostatin, somatostatin receptors, and pancreatic cancer.

Authors:  Min Li; William E Fisher; Hee Joon Kim; Xiaoping Wang; Charles F Brunicardi; Changyi Chen; Qizhi Yao
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

Review 6.  Pancreatic cancer - a continuing challenge in oncology.

Authors:  Attila Zalatnai
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

7.  Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas.

Authors:  H Oka; L Jin; J C Reubi; X Qian; B W Scheithauer; K Fujii; T Kameya; R V Lloyd
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro.

Authors:  Manoj Kumar; Zheng-Ren Liu; Laxmi Thapa; Qing Chang; Da-Yu Wang; Ren-Yi Qin
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

9.  MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors.

Authors:  Rui Gradiz; Henriqueta C Silva; Lina Carvalho; Maria Filomena Botelho; Anabela Mota-Pinto
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.